Literature DB >> 10329529

Effects of asymptomatic abdominal aortic aneurysm on the soluble coagulation system, platelet count and platelet activation.

A A Milne1, D J Adam, W G Murphy, C V Ruckley.   

Abstract

OBJECTIVES: the aim of the study was to determine the effects of infrarenal asymptomatic abdominal aortic aneurysm (AAA) on platelet count and activation.
DESIGN: prospective clinical study in a University Department of Vascular Surgery. PATIENTS: one hundred and five patients with AAA. Thirty-two control patients with symptomatic carotid artery stenoses.
METHODS: platelet count (PC), plasma glycocalicin levels, prothrombin ratio (PTR), activated partial thromboplastin time (APPT), fibrinogen and D-dimer were measured in 23 patients with AAA and 16 control patients with symptomatic carotid artery stenoses. PC alone was measured in a further 84 patients with AAA and 16 with carotid artery stenoses.
RESULTS: PC was below the normal range in 8/105 patients and mean PC (215x10(9)/l, S.D. 47.5) was significantly lower than that of a control population (242x10(9)/l, S.D. 16.8) and patients with carotid disease (269x10(9)/l, S.D. 57). Glycocalicin level was above the normal range in 7/23 patients and the median level (28 fg/plt) was significantly higher than that of a normal population (21.6 fg/plt) and patients with carotid disease (12.3 fg/plt). Fibrinogen levels, PTR and APPT were all within the normal range. One patient had a minimally elevated level of D-dimer.
CONCLUSIONS: the combination of low PC and high glycocalicin levels suggests that there is increased platelet destruction, most likely due to activation within the aneurysm sac. Copyright 1999 W.B. Saunders Company Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329529     DOI: 10.1053/ejvs.1998.0790

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

Review 1.  Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.

Authors:  Weiliang Sun; Jingang Zheng; Yanxiang Gao
Journal:  Biomolecules       Date:  2022-01-25

Review 2.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690

3.  D-Dimer Is a Diagnostic Biomarker of Abdominal Aortic Aneurysm in Patients With Peripheral Artery Disease.

Authors:  Huoying Cai; Baihong Pan; Jie Xu; Shuai Liu; Lei Wang; Kemin Wu; Pu Yang; Jianhua Huang; Wei Wang
Journal:  Front Cardiovasc Med       Date:  2022-06-03

Review 4.  The Detrimental Role of Intraluminal Thrombus Outweighs Protective Advantage in Abdominal Aortic Aneurysm Pathogenesis: The Implications for the Anti-Platelet Therapy.

Authors:  Xiaoying Ma; Shibo Xia; Guangqin Liu; Chao Song
Journal:  Biomolecules       Date:  2022-07-05

Review 5.  Platelet function changes in patients undergoing endovascular aortic aneurysm repair: Review of the literature.

Authors:  Anna Burban; Aleksandra Idzik; Agata Gelo; Krzysztof J Filipiak; Tomasz Jakimowicz; Katarzyna Jama; Marcin Grabowski; Aleksandra Gasecka; Aleksander Siniarski
Journal:  Front Cardiovasc Med       Date:  2022-08-12

Review 6.  Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?

Authors:  Scott J Cameron; Hannah M Russell; A Phillip Owens
Journal:  Blood       Date:  2018-09-18       Impact factor: 25.476

7.  Two C-C Family Chemokines, Eotaxin and RANTES, Are Novel Independent Plasma Biomarkers for Abdominal Aortic Aneurysm.

Authors:  Gregory T Jones; L Victoria Phillips; Michael J A Williams; Andre M van Rij; Tasnuva D Kabir
Journal:  J Am Heart Assoc       Date:  2016-04-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.